Tel: 01223 746857
Dr Babb de Villiers completed her undergraduate studies at the University of Liverpool (BSc) and Glasgow University (MSc Medical Genetics). She then did a PhD at Stellenbosch University, South Africa where she investigated candidate genes for association with tuberculosis in the South African Cape Coloured population. This is a unique population with a diverse genetic background that allowed her to gain experience in working on complex genetic profiles. Once graduating, she joined the Somatic Cell Genetics Unit’s research and development unit in the Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg. She joined the cancer molecular diagnostic laboratory. She developed diagnostic tests and researched the molecular profile of HIV associated lymphomas, GIST and colorectal cancers. Wanting to do more research she transferred to the South African National Cancer Registry, NHLS Cancer Epidemiology Research Group (CERG) where she was the lead Medical Scientist on the Johannesburg Cancer Case Control Study (JCCCS). At the NCR she gained experience in cancer epidemiology and was awarded a Union for International Cancer Control International Cancer Technology Transfer Fellowship to the Cancer Council NSW, Sydney (Australia).
Schonfeld SJ, Erdmann F, Wiggill F, Singh E, Kellett P, Babb C and Schüz J. Hematologic malignancies in South Africa 2000-2006: Analysis of data reported to the National Cancer Registry. Cancer Medicine 2016
Halec G, Schmitt M, Egger S, Abnet CC, Babb C, Dawsey SM, Flechtenmacher C, Gheit T, Hale M, Holzinger D, Malekzadeh R, Taylor PR, Tommasino M, Urban MI, Waterboer T, Pawlita M, Sitas F; InterSCOPE Collaboration. Mucosal Alpha-Papillomaviruses are not associated with Esophageal Squamous Cell Carcinomas: Lack of Mechanistic Evidence from South Africa, China and Iran and from a World-Wide Meta-Analysis. Int J Cancer. 2015 Nov 3. doi: 10.1002/ijc.29911
Singh E, Ruff P, Babb C, Sengayi M, Beery M, Khoali L, Kellett P, Underwood JM. Establishment of a cancer surveillance programme: the South African experience. Lancet Oncology Volume 16, No. 8, e414–e421, August 2015. DOI: http://dx.doi.org/10.1016/S1470-2045(15)00162-X
Sengayi M, Babb C, Egger M and Urban MI. HIV testing and burden of HIV infection in black cancer patients in Johannesburg, South Africa: A cross-sectional study. BMC Cancer 2015 15:144 (doi 10.1186/s12885-015-1171-7)
Mendy M, Caboux E, Sylla BS, Dillner J, Chinquee J, Wild C and BCNet survey participants (incl Babb C). Infrastructure and Facilities for Human Biobanking in Low- and Middle-Income Countries – A situational analysis. Pathobiology 2014; 81:252-260
Beral V, Gaitskell K, Hermon C, Moser K, Reeves G and Peto R on behalf of Collaborative Group on Epidemiological Studies of Ovarian Cancer (incl Babb C and Urban M). Menopausal hormone use and ovarian cancer risk: Individual participant meta-analysis of 52 epidemiological studies. The Lancet Feb 13 Online (2014).
Singh E, Sengayi M, Underwood JM, Nattey C, Babb C, Beery M, Maphanga T, Kellett P. South African National Cancer Registry: Effect Of Witheld Data From Private Health Systems On Cancer Incidence Estimates. SAMJ (2015) Vol 105, No 2, pages 107-109.
Babb C, Urban M, Kielkowski D, and Kellett P. Prostate Cancer in South Africa: Pathology Based National Cancer Registry Data (1986–2006) and Mortality Rates (1997–2009), Prostate Cancer, Volume 2014 May (2014), Article ID 419801, 9 pages
Baker GL, Babb C, Schnugh DJ, Naylor SJ, Louw M, Goedhals J, Bringuier P, Blay J, Willem P. Molecular characterization of gastrointestinal stromal tumours (GISTs) in a South African population. Oncology Letters 2013 Jan;5(1):155-160.
Boy SC, van Heerden MB, Babb C, van Heerden WF, Willem P. Dominant genetic aberrations and coexistent EBV infection in HIV-related oral plasmablastic lymphomas. Oral Oncol. 2011 Sep;47(9):883-7.
Honorary Associate Researcher at the University of the Witwatersrand, School of Pathology, Faculty of Health Sciences, Division of Human Genetics.